WASHINGTON — Entyvio is “safe and effective” for maintaining sustained steroid-free remission at 1 year in children with inflammatory bowel disease, more so in those with ulcerative colitis vs. Crohn’s disease, according to a researcher.
“We know that children with inflammatory bowel disease, compared to adults, can have a more severe disease phenotype that is